Boston Financial & Equity Corporation closed a $250,000 equipment lease line with a drug discovery company based in Pittsburgh, PA. The company, founded in 2010, has generated revenue from big pharmaceuticals such as Pfizer, Merck and Amgen but is still a ways away from profitability.

The company brings a newly created way to bring targeted biosensors to the cellular biology research community. While the company does not expect to be profitable until 2017, they have raised $1 million to date. With 10 to 12 months of cash at their current burn rate, and fungible assets with strong resale values, we gave them a 36 month master equipment lease.